The Latest in ICYMI Multiple Sclerosis

Physical activity is a growing priority for patients with MS

March 8, 2023

Multiple Sclerosis

New digital tools hold promise for patients with MS

March 8, 2023

Multiple Sclerosis

MS looks homogeneous

March 8, 2023

Multiple Sclerosis

Portable MRI has potential for MS

March 6, 2023

Multiple Sclerosis

A better MS measure?

March 2, 2023

Multiple Sclerosis

Cutting calories may benefit cognition in MS

March 2, 2023

Multiple Sclerosis

High level of psychiatric morbidity in prodromal MS

March 2, 2023

Multiple Sclerosis

MOGAD: Immunotherapy predicts fewer relapses

March 1, 2023

Multiple Sclerosis

To prevent MS, should we target EBV?

February 28, 2023

Multiple Sclerosis

Differential diagnosis in MS: What to watch for

February 28, 2023

Multiple Sclerosis

CBT alone and with meds may decrease MS fatigue

February 27, 2023

Multiple Sclerosis

Anti-CD20 Monoclonal Antibodies for Treating Multiple Sclerosis

February 10, 2023

Multiple Sclerosis

Biosimilar equal to natalizumab for relapsing remitting MS

February 1, 2023

Multiple Sclerosis

Despite ongoing challenges, experts are optimistic about the future of MS therapy

January 25, 2023

Multiple Sclerosis

Stem cell transplant superior to DMTs for secondary progressive MS

January 3, 2023

Multiple Sclerosis